Advances and Challenges in Nanoemulsion for Diabetes Management: An Emerging Framework

Abstract: Nanoemulsions have emerged as versatile nanoscale delivery systems capable of enhancing drug permeation, stability, and therapeutic efficiency across transdermal, dermal, and oral routes. In diabetes management, conventional therapies often suffer from limited bioavailability, rapid systemic clearance, and the need for frequent dosing, resulting in fluctuating glycemic control and reduced patient adherence. Nanoemulsion-based formulations offer a promising alternative by improving solubility, enhancing mucosal and skin penetration, protecting labile drugs, and enabling controlled or targeted release. Recent advances in semisolid and hybrid nanoemulsion systems have further strengthened their potential by addressing long-standing challenges related to physical stability, dose conversion, and scalability. Nanotechnology-driven approaches, including PEGylation, ligand functionalization, and encapsulation within lipid or polymeric nanocarriers, have shown particular promise for peptide-based antidiabetic drugs such as GLP-1 analogues. These modifications enhance gastrointestinal stability, prolong circulation time, and improve targeted delivery to metabolic tissues. Additionally, nanoemulsions support multimodal delivery, enabling both transdermal insulin options and oral delivery strategies that bypass first-pass metabolism. Beyond pharmaceuticals, nanoemulsion technology is widely used in skincare, agriculture, food processing, and the cosmetic industries—illustrating its flexibility in formulation, safety, and cost-effective manufacturing. For diabetes, however, challenges remain, including physicochemical instability, potential toxicity of surfactants, regulatory hurdles, and the need for standardized scale-up methods. This review provides a comprehensive overview of emerging nanoemulsion platforms for diabetes therapy, highlighting recent innovations, therapeutic advantages, and key translational challenges. By integrating advancements in formulation science and nanotechnology, nanoemulsions represent a rapidly evolving framework with significant potential to transform future diabetes management.